Form 4: Hims & Hers Health Chief Legal Officer Sells Shares
SEC Filing
Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,335 shares of Class A Common Stock at a price of $20.28 on July 9, 2024, according to a Form 4 filing with the SEC.
Summary
- On July 9, 2024, Soleil Boughton, the Chief Legal Officer of Hims & Hers Health, Inc., sold 2,335 shares of Class A Common Stock.
- The sale was executed at a price of $20.28 per share.
- Following the transaction, Boughton directly owns 169,144 shares of Hims & Hers Health, Inc.
- The sale was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on September 10, 2023.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction was pre-planned under a 10b5-1 trading plan. It doesn't necessarily indicate a positive or negative outlook on the company's future.
Industry Context
Insider sales are a common occurrence and are often scrutinized by investors as they can provide insights into management's perspective on the company's valuation and future prospects. However, sales under pre-arranged 10b5-1 plans are typically less indicative of immediate sentiment as they are planned in advance.
Stakeholder Impact
- The sale of shares by a high-ranking officer could potentially influence investor sentiment, although the impact is likely to be minimal due to the pre-planned nature of the transaction.
Key Dates
| Date | Description |
|---|---|
| 2023-09-10 | Date of adoption of Rule 10b5-1 trading plan |
| 2024-07-09 | Date of transaction (stock sale) |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.